Time course of changes in the list of drugs for the treatment of COVID-19 in the temporary guidelines

DOI: https://doi.org/10.29296/25877305-2021-11-06
Download full text PDF
Issue: 
11
Year: 
2021

Ya. Shirobokov(1); Professor E. Gladunova(1), PharmD; Professor E. Borodulina(1), MD; Professor
D. Kudlay(2, 3), MD; Associate Professor L. Povalyaeva(1), Candidate of Medical Sciences (1)Samara State
Medical University (2)I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of
Health of Russia (3)State Research Center “Institute of Immunology”, Federal Biomedical Agency of Russia,
Moscow

To identify the features of treatment for coronavirus infection (COVID-19), the authors have analyzed changes in the list of drugs and treatment regimens described in the temporary clinical guidelines.
Keywords: 
infectious diseases
COVID-19
coronavirus infection
community-acquired pneumonia
drug provision
temporary clinical guidelines

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Borodulina E.A., Shirobokov Ja.E., Gladunova E.P. i dr. Diagnostika i farmakoterapija virus-assotsiirovannyh porazhenij legkih. Klinicheskaja farmakologija i terapija. 2020; 29 (3): 61–6 [Borodulina E.A., Shirobokov Y.E., Gladunova E.P. et al. Virus-associated lung disease. Clinical pharmacology and therapy. 2020; 29 (3): 61–6 (in Russ.)]. DOI: 10.32756/0869-5490-2020-3-61-66
  2. Kudlaj D.A., Shirobokov Ja.E., Gladunova E.P. i dr. Diagnostika COVID-19. Sposoby i problemy obnaruzhenija virusa SARS-CoV-2 v uslovijah pandemii. Vrach. 2020; 31 (8): 5–10 [Kudlay D., Shirobokov Ya., Gladunova E. et al. Diagnosis of COVID-19. Methods and problems of virus SARS-CoV-2 detection under pandemic conditions. Vrach. 2020; 31 (8): 5–10 (in Russ.)]. https://doi.org/10.29296/25877305-2020-08-01
  3. Malkova A., Kudlay D., Kudryavtsev I. et al. Immunogenetic Predictors of Severe COVID-19. Vaccines. 2021; 9: 211. DOI: 10.3390/vaccines9030211
  4. Starshinova A.A., Kushnareva E.A., Kudlaj D.A. i dr. Vozmozhnosti lechenija bol'nyh s COVID-19: analiz dannyh literatury. Transljatsionnaja meditsina. 2020; 7 (3): 30–7 [Starshinova A.A., Kushnareva E.A., Kudlay D.A. et al. Prospects for a COVID-19 treatment: review. Translational Medicine. 2020; 7 (3): 30–7 (in Russ.)]. DOI: 10.18705/2311-4495-2020-7-3-30-37
  5. Gudima G.O., Haitov R.M., Kudlaj D.A. i dr. Molekuljarno-immunologicheskie aspekty diagnostiki, profilaktiki i lechenija koronavirusnoj infektsii. Immunologija. 2021; 42 (3): 198–210 [Gudima G.O., Khaitov R.M., Kudlay D.A. et al. Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198–210 (in Russ.)]. DOI: 10.33029/0206-4952-2021-42-3-198-210
  6. Kozlov V.A., Savchenko A.A., Kudrjavtsev I.V. i dr. Klinicheskaja immunologija. Krasnojarsk: Polikor, 2020; 386 s. [Kozlov V.A., Savchenko A.A., Kudryavtsev I.V. et al. Klinicheskaya immunologiya. Krasnoyarsk: Polikor, 2020; 386 s. (in Russ.)]. DOI: 10.17513/np.438
  7. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (2019-nCoV). Vremennye metodicheskie rekomendatsii. Versija 2 (03.02.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (2019-nCoV). Vremennye metodicheskie rekomendatsii. Versiya 2 (03.02.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
  8. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (2019-nCoV). Vremennye metodicheskie rekomendatsii. Versija 3 (03.03.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (2019-nCoV). Vremennye metodicheskie rekomendatsii. Versiya 3 (03.03.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
  9. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 4 (27.03.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 4 (27.03.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
  10. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected. Interim guidance, 2020.
  11. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 5 (08.04.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 5 (08.04.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
  12. Pogue J.M., Kaye K.S., Veve M. et al. 2406. «Real-world» Treatment of Multidrug-Resistant (MDR) or Extensively Drug-Resistant (XDR) P. aeruginosa Infections With Ceftolozane/Tazobactam (C/T) vs. a Polymyxin or Aminoglycoside (Poly/AG)-based Regimen: A Multicenter Comparative Effectiveness Study. Open Forum Infect Dis Oxford University Press (OUP). 2018; 5 (№ suppl. 1): S719–S719. DOI: 10.1093/ofid/ofy210.2059
  13. Karpova L.S., Sominina A.A., Dmitrieva M.N. i dr. Sravnitel'nyj analiz pandemii grippa a(H1N1)pdm09 v Rossii (2009–2010 gg.) i posledujuschih epidemij (2011–2014 gg.). Epidemiologija i vaktsinoprofilaktika. 2014; 6 (79): 8–16 [Karpova L.S., Sominina A.A., Dmitrieva M.N. et al. Sravnitel’nyi analiz pandemii grippa a(H1N1)pdm09 v Rossii (2009–2010 gg.) i posleduyushchikh epidemii (2011–2014 gg.). Epidemiologiya i vaktsinoprofilaktika. 2014; 6 (79): 8–16 (in Russ.)].
  14. Stovba L.F., Lebedev V.N., Petrov A.A. i dr. Novyj koronavirus, vyzyvajuschij zabolevanie cheloveka. Problemy osobo opasnyh infektsij. 2015; 2: 68–74 [Stovba L.F., Lebedev V.N., Petrov A.A. et al. Emerging Coronavirus Which Gives Rise to the Disease in Humans. Problems of Particularly Dangerous Infections. 2015; 2: 68–74 (in Russ.)]. DOI: 10.21055/0370-1069-2015-2-68-74
  15. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 6 (24.04.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 6 (24.04.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
  16. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 7 (03.06.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 7 (03.06.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
  17. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 8.1 (01.10.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 8.1 (01.10.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
  18. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 8 (03.09.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 8 (03.09.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
  19. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 9 (26.10.2020). M.: Minzdrav Rossii, 2020 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 9 (26.10.2020). M.: Minzdrav Rossii, 2020 (in Russ.)].
  20. Profilaktika, diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 10 (08.02.2020). M.: Minzdrav Rossii, 2021 [Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 10 (08.02.2020). M.: Minzdrav Rossii, 2021 (in Russ.)].
  21. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 11 (07.05.2021). M.: Minzdrav Rossii, 2021 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 11 (07.05.2021). M.: Minzdrav Rossii, 2021 (in Russ.)].
  22. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 12 (21.09.2021). M.: Minzdrav Rossii, 2021 [Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 12 (21.09.2021). M.: Minzdrav Rossii, 2021 (in Russ.)].
  23. Ministerstvo zdravoohranenija Rossijskoj Federatsii. Profilaktika diagnostika i lechenie novoj koronavirusnoj infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versija 13 (14.10.2021). M.: Minzdrav Rossii, 2021 [Ministerstvo zdravookhraneniya Rossiiskoi Federatsii. Profilaktika diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19). Vremennye metodicheskie rekomendatsii. Versiya 13 (14.10.2021). M.: Minzdrav Rossii, 2021 (in Russ.)].
  24. Tang Y., Liu J., Zhang D. et al. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front Immunol. 2020; 11: 1708. DOI: 10.3389/fimmu.2020.01708
  25. Coomes E.A., Haghbayan H. Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev Med Virol. 2020; 30 (6): 1–9. DOI: 10.1002/rmv.2141
  26. Asakura H., Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol. 2021; 113 (1): 45–57. DOI: 10.1007/s12185-020-03029-y
  27. Luo L., Xu M., Du M. et al. Early coagulation tests predict risk stratification and prognosis of COVID-19. Aging (Albany NY). 2020; 12 (16): 15918–37. DOI: 10.18632/aging.103581
  28. Hunt B.J., De Paula E. V., McLintock C. et al. Prophylactic anticoagulation for patients in hospital with COVID-19. BMJ. 2021; 372: n487. DOI: 10.1136/bmj.n487
  29. Horby P., Lim W.S., Emberson J.R. et al. RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021; 384 (8): 693–704. DOI: 10.1056/NEJMoa2021436
  30. Sterne J.A.C. et al. Association between Administration of Systemic Corticosteroids and Mortality among Critically Ill Patients with COVID-19: A Meta-analysis. JAMA. 2020; 324 (13): 1330–41. DOI: 10.1001/jama.2020.17023